Latest KFF Health News Content

Latest KFF Health News Stories

‘An Arm And A Leg’: A La ‘Hamilton,’ Revue Takes On History Of Health Insurance

KFF Health News Original

Kvetching about the cost of health care is kind of what we do on the podcast “An Arm and a Leg.” This week’s episode features like-minded storytellers — from the musical troupe Heck No Techo — who have turned their frustrations into art and laughter.

KHN’s ‘What The Health?’: How’s That Open Enrollment Going?

KFF Health News Original

Open enrollment for the Affordable Care Act’s marketplace plans is halfway over and, so far, the number of people signing up is down, but not dramatically. Meanwhile, Congress and President Donald Trump can’t seem to agree on what to do about teen vaping, drug prices or “surprise” medical bills. And Democrats lurch to the left on abortion. Paige Winfield Cunningham of The Washington Post, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more health news.

University Backtracks On Decision Not To Let Students Use Medicaid After Being Thrust In National Spotlight

Morning Briefing

Reports that Brigham Young University-Idaho wouldn’t accept Medicaid as acceptable insurance for students prompted an outcry of criticism. The university had claimed the change was due to the impracticality for the local medical community to provide for the health care needs for the students, but local providers disputed that reasoning.

CMS Spent Millions On Tool To Help Medicare Beneficiaries, But It’s Giving Seniors Wrong Info On Plans

Morning Briefing

CMS revamped its system to help beneficiaries navigate Medicare enrollment, but the newly redesigned tool has been causing confusion for many instead. The flawed results being shown include inaccurate premium estimates, incorrect prescription drug costs and inaccurate costs with extra help subsidies.

Lawmakers Optimistic About Breaking Stalemate On Stalled Surprise Billing Negotiations

Morning Briefing

While many in Congress are agreed that something must be done to address surprise medical bills, the lawmakers have been split over which of a handful of strategies to choose in moving forward. In other health industry and insurance news: record-high debt, gender pay gaps, state health exchanges, and more.

‘Trying To Reduce Anxiety’: Instagram Explores Ways To Take Away Likes, Improve Mental Health

Morning Briefing

By removing users ability to see how many likes their followers got but allowing them to see likes on their own posts, might make social media less stressful. But marketing agencies say the change would not be beneficial for businesses looking to market through high-profile users. Other news on mental health comes from California, Connecticut, Wisconsin and Illinois.

Behind The Thousands Of Lawsuits Against Roundup Weed Killer Lurks A Sophisticated, Little-Known Legal Ecosystem

Morning Briefing

The Wall Street Journal lifts the curtain on the behind-the-scenes work to build a public health legal challenge against a big company. In other public health news: football and CTE, caregivers, bias in science, dementia fears, screen time for toddlers, foster care, and more.

In Lawsuit, Generic Drug Group Says California’s Ban On Pay-To Delay Deals Would Hurt Competition

Morning Briefing

The FTC, however, says the deals cost U.S. consumers an estimated $3.5 billion annually. In other pharmaceutical news: anti-trust probes, a billionaire couple’s work to move the House drug pricing bill through, the strategy behind Novartis’ recent acquisition, brain boosting supplements, and more.

FDA Approves New Sickle Cell Drug As Part Of Flood Of New Treatments For The Disease

Morning Briefing

“Everybody’s been waiting for this moment where the flood gate of new treatments is opening,” said Dr. Biree Andemariam, chief medical officer of the Sickle Cell Disease Association of America. But the new drug is expensive: Global Blood Therapeutics priced Oxbryta at $125,000 a year.

PhRMA To Yank Millions In Funding From Nonprofit Geared Toward Helping Those Addicted To Opioids

Morning Briefing

PhRMA, which is responsible for 90 percent of the Addiction Policy Forum’s funding, will walk back and then end its support by 2020. The forum was at the eye of previous controversy, with critics blasting the fact that most of its funding came from the drugmakers who they said were responsible for the crisis in the first place. News on the opioid epidemic comes out of Massachusetts and Ohio, as well.